OverT builds scalable, cost-effective immune therapies for solid tumors using its data-driven discovery platformsNEW ...
Spear Bio, an innovator in ultrasensitive protein biomarker detection, showcased three new SPEAR UltraDetect™ ...
TAMPA, FL / ACCESS Newswire / March 23, 2026 / Wellgistics Health, Inc. ("Wellgistics" or the "Company") (NASDAQ:WGRX) today ...
GaN-Based HWLLC Converter Topology Sets New Power Density and Peak Efficiency Benchmarks for Next-Generation Computing ...
Acquisition Adds Clinical Stage Bispecific BCMAxCD3 T Cell Engager with Potential for Durable Immune Reset to Gilead’s ...
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, will highlight the latest sudden cardiac death research, case experiences for heart failure readmission ...
The impending right to strike raises alarms over a "structural supply chain risk" for the 24/7 global biopharmaceutical supply chain.The union points to a systemic failure in labor compliance, ...
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for ...
FDA clearance quickly follows Photonova Spectra’s debut at the Radiological Society of North America (RSNA) 2025 Annual ...
Amani Therapeutics, a newly formed biotechnology company backed by RTW Investments, today announced the closing of a $25 ...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that ...
Positive Phase 3 results of SCOUT-HCM trial highlight potential of Camzyos to be the first cardiac myosin inhibitor for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results